Current Assets

Total Debt Securities (Trading and AFS)

Pfizer Total Debt Securities (Trading and AFS) decreased by 3.6% to $9.55B in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026May 5, 2026

How to read this metric

An increase indicates a larger allocation to liquid debt instruments, which may signal a defensive posture or increased liquidity needs.

Detailed definition

This represents the aggregate carrying value of debt securities classified as either trading or available-for-sale. Thes...

Peer comparison

Standard metric for all major financial institutions with significant investment or trading operations.

Metric ID: debt_securities_trading_afs_total

Historical Data

2 periods
 Q4 '25Q1 '26
Value$9.91B$9.55B
QoQ Change—-3.6%
Range$9.55B – $9.91B

Total Debt Securities (Trading and AFS) at Other Companies

Bank of America logo
Bank of AmericaBACView metric
Bank of America logo
Bank of AmericaBACView metric
Bank of America logo
Bank of AmericaBACView metric
M&T Bank logo
M&T BankMTBView metric
Bank of America logo
Bank of AmericaBACView metric
Truist Financial logo
Truist FinancialTFCView metric

Frequently Asked Questions

What is Pfizer's total debt securities (trading and afs)?
Pfizer (PFE) reported total debt securities (trading and afs) of $9.55B in Q1 2026.
What does total debt securities (trading and afs) mean?
The total value of debt investments held for trading or potential sale, measured at current market prices.